Affiliation:
1. 1Memorial Sloan Kettering Cancer Center, New York, New York.
Abstract
Summary
Well-annotated matched tissue specimens both before and after initiation of androgen receptor signaling inhibitors (ARSI) have revealed activation of unique signaling pathways and genomic signatures that identify a profile to guide therapy. A recent study represents the largest prospective biospecimen banking protocol to study mechanisms of resistance to ARSIs.
See related article by Menssouri et al., p. 4504
Publisher
American Association for Cancer Research (AACR)